ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Oncternal Therapeutics Appoints Pablo Urbaneja as SVP, Corporate Development
July 02, 2021Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the appointment of Pablo Urbaneja as Senior Vice President, Corporate Development. -
Oncternal gets FDA orphan drug designations for cirmtuzumab to treat MCL and CLL
July 06, 2020Oncternal Therapeutics announced that the United States Food and Drug Administration (FDA) has granted the company orphan drug designations of cirmtuzumab for treatment of mantle cell lymphoma (MCL) and for treatment of chronic lymphocytic leukaemia ...
Pharma Sources Insight January 2025
